Article ID Journal Published Year Pages File Type
8245675 International Journal of Radiation Oncology*Biology*Physics 2006 6 Pages PDF
Abstract
Conclusions: The MTD of the RT was 74 Gy with weekly carboplatin and paclitaxel. The Phase II portion of this trial is currently under way. The goal is to improve local control and survival with higher doses of RT delivered with this combined modality approach.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer
Authors
, , , , , , , , , , , ,